Skip to main content
TipRanks
Go Ultimate75% OFF

Mark Diamond Insider Profile

4 Followers

Mark Diamond, Managing Director at Percheron Therapeutics, holds 4.89M shares in Percheron Therapeutics (Ticker: PERCF). Most recently, Mark Diamond Bought 263,158 shares of Percheron Therapeutics on Feb 13, 2017 for an estimated value of $10.00K.

Mark Diamond's Trading History

PERCF
Percheron Therapeutics
Feb 13, 2017Managing DirectorInformative Buy10.00K$48.94K
PERCF
Insider Shares: 4.89M (74.39%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Feb 13, 2017Informative BuyAU$10.00K263,158AU$0.040.00%―
Oct 21, 2015Informative BuyAU$9.00K100,000AU$0.09-39.20%―
Nov 12, 2014Informative BuyAU$35.00K304,348AU$0.12-40.00%―
Apr 17, 2013Informative BuyAU$4.83K483,400AU$0.01――
Mar 25, 2013Informative BuyAU$12.00K1,000,000AU$0.01――

You May Also Like

Mark Diamond insider profile FAQ

What is the percentage of profitable transactions made by Mark Diamond?
The percentage of profitable transactions made by Mark Diamond is 0%.
What is the average return per transaction made by Mark Diamond?
The average return per transaction made by Mark Diamond is -26.40%.
What stocks does Mark Diamond hold?
Mark Diamond holds: PERCF stocks.
What was Mark Diamond’s latest transaction?
Mark Diamond’s latest transaction was an Informative Buy of $10.00K.
What was Mark Diamond's most profitable transaction?
Mark Diamond’s most profitable transaction was an Informative Buy of PERCF stock on February 13, 2017. The return on the trade was 0.00%.
What is Mark Diamond's role in Percheron Therapeutics?
Mark Diamond's role in Percheron Therapeutics is Managing Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.